Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
29.76
-0.23 (-0.77%)
Feb 20, 2026, 4:00 PM EST - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.42 billion as of February 23, 2026. Its market cap has increased by 120.96% in one year.
Market Cap
1.42B
Enterprise Value
917.24M
1-Year Change
120.96%
Ranking
Category
Stock Price
$29.76
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.42B, an increase of 135.85%. That is a compound annual growth rate of 65.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.42B | -1.91% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.48B |
| Intellia Therapeutics | 1.47B |
| uniQure | 1.46B |
| AtaiBeckley | 1.42B |
| Ardelyx | 1.41B |
| Corvus Pharmaceuticals | 1.39B |
| Zenas BioPharma | 1.38B |
| Savara | 1.37B |